These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23725096)

  • 21. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
    Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
    Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cough and phlegm are important predictors of health status in smokers without COPD.
    Heijdra YF; Pinto-Plata VM; Kenney LA; Rassulo J; Celli BR
    Chest; 2002 May; 121(5):1427-33. PubMed ID: 12006424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
    Koo HK; Hoth KF; Make BJ; Regan EA; Crapo JD; Silverman EK; DeMeo DL
    Respir Res; 2022 Jan; 23(1):19. PubMed ID: 35093071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spirometric Interpretation and Clinical Relevance According to Different Reference Equations.
    Lee HW; Lee JK; Hwang YI; Seo H; Ahn JH; Kim SR; Kim HJ; Jung KS; Yoo KH; Kim DK
    J Korean Med Sci; 2024 Jan; 39(4):e20. PubMed ID: 38288534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores.
    Jones PW; Tabberer M; Chen WH
    BMC Pulm Med; 2011 Aug; 11():42. PubMed ID: 21835018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the COPD Assessment Test sensitive for differentiating COPD patients from active smokers and nonsmokers without lung function impairment? A population-based study.
    Karloh M; Rocha SAV; Pizzichini MMM; Cavalli F; Matte DL; Pizzichini E;
    J Bras Pneumol; 2018; 44(3):213-219. PubMed ID: 30043888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter family practitioners' research on Chronic Obstructive Pulmonary Disease screening using the COPD Assessment Test.
    Demirci H; Eniste K; Basaran EO; Ocakoglu G; Yilmaz Z; Tuna S
    Prim Health Care Res Dev; 2017 Nov; 18(6):603-607. PubMed ID: 28714435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.
    Houben-Wilke S; Spruit MA; Uszko-Lencer NHMK; Otkinska G; Vanfleteren LEGW; Jones PW; Wouters EFM; Franssen FME
    Respirology; 2017 Jul; 22(5):928-934. PubMed ID: 28001000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
    Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
    Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey.
    Solem CT; Sun SX; Liu S; Macahilig C; Katyal M; Gao X; Shorr AF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():991-8. PubMed ID: 25284999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
    Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maximal mid-expiratory flow detects early lung disease in α
    Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the Effectiveness of the COPD Assessment Test (CAT) in Screening for Chronic Obstructive Pulmonary Disease.
    Al Wachami N; Boumendil K; Arraji M; Iderdar Y; Mourajid Y; Ghosne N; Benmoussa A; Khalis M; Korrida A; Laamiri FZ; Lajane H; Louerdi ML; El Madani S; Chahboune M
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1623-1633. PubMed ID: 39011121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.